Over-the-top (OTT) services are considered to be online mobile applications that are typically provided by third parties through app stores and often consume significant mobile network bandwidth. With billions of users, OTT services already have huge scale and still have further growth potential...
Over-the-top (OTT) services are considered to be online mobile applications that are typically provided by third parties through app stores and often consume significant mobile network bandwidth. With billions of users, OTT services already have huge scale and still have further growth potential...
London, 10 July 2017 – In its latest report ‘5G Deployment Models Are Crystallizing’, Arthur D. Little (ADL) examines the opportunities that exist for telecom operators to facilitate new business ecosystems enabled by the next generation of mobile networks.
Digital disruption is evident across all industries driven by changing customer preferences, new digital competitors and access to new technologies. The telecom industry is no exception to this with shrinking revenues in traditional business ; yet, new opportunities are emerging as industry...
Over the last decades, the Middle East has witnessed fast population growth, from 186 million people in 1990 to 323 million in 2015. Its urbanization rate has increased rapidly during the same period, from 54 percent in 1990 to 63 percent in 2015.
Telecom operators have a real opportunity to reduce operational costs by 30-40% whilst improving service quality and customer satisfaction.
This is primarily achieved by reducing / eliminating operational complexities accumulated during the growth phase and digitalizing the operations...
Telecom operators have a real opportunity to reduce operational costs by 30-40% whilst improving service quality and customer satisfaction.
This is primarily achieved by reducing / eliminating operational complexities accumulated during the growth phase and digitalizing the operations...
The cost of the clinical trial process today is upwards of $100mn. So how can drug developers with robust R&D pipelines but a limited operating budget make the most of their portfolios and get as many promising new therapies to market in the narrow window before patents expire?
The cost of funding a clinical trial today can run biopharma companies upwards of $100mn, and that does not even begin to consider the costs of marketing and distribution necessary for a new life enhancing therapy to reach patients’ hands.
E-learning leverages slide shows, videos, gamification and simulation to create interactive discussions and knowledge sharing in digital format. It is a quick and flexible way to train a large number of employees, independent of physical location and time, and create attractive opportunities to...